HB 443 – New HampshireStatus: Inactive / Dead
Year Introduced: 2017
PROHIBITING PRESCRIPTION DRUG MANUFACTURERS FROM OFFERING COPAYMENT REIMBURSEMENT: No prescription drug manufacturer doing business in New Hampshire shall establish a copayment reimbursement program or otherwise offer to pay, waive, or reimburse a patient for his or her insurance copayment.
Return to Database Search
© 2018-2019 The SLIHCQ Database. Initial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.